RISANAMENTO SPA (RN.MI) Fundamental Analysis & Valuation

BIT:RN • IT0001402269

Current stock price

0.017 EUR
0 (-5.56%)
Last:

This RN.MI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. RN.MI Profitability Analysis

1.1 Basic Checks

  • In the past year RN has reported negative net income.
  • In the past year RN had a positive cash flow from operations.
  • In the past 5 years RN reported 4 times negative net income.
  • In the past 5 years RN reported 4 times negative operating cash flow.
RN.MI Yearly Net Income VS EBIT VS OCF VS FCFRN.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M -40M -60M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -17.00%, RN is doing worse than 78.13% of the companies in the same industry.
  • The Return On Equity of RN (-1954.84%) is worse than 81.25% of its industry peers.
Industry RankSector Rank
ROA -17%
ROE -1954.84%
ROIC N/A
ROA(3y)-10.95%
ROA(5y)-7.97%
ROE(3y)-342.17%
ROE(5y)-214.79%
ROIC(3y)N/A
ROIC(5y)N/A
RN.MI Yearly ROA, ROE, ROICRN.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400 -600 -800

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for RN so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
RN.MI Yearly Profit, Operating, Gross MarginsRN.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -10K -20K -30K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

1

2. RN.MI Health Analysis

2.1 Basic Checks

  • RN does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for RN remains at a similar level compared to 1 year ago.
  • RN has about the same amout of shares outstanding than it did 5 years ago.
  • The debt/assets ratio for RN is higher compared to a year ago.
RN.MI Yearly Shares OutstandingRN.MI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B
RN.MI Yearly Total Debt VS Total AssetsRN.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

  • RN has an Altman-Z score of -0.86. This is a bad value and indicates that RN is not financially healthy and even has some risk of bankruptcy.
  • RN has a worse Altman-Z score (-0.86) than 75.00% of its industry peers.
  • RN has a Debt/Equity ratio of 1.42. This is a high value indicating a heavy dependency on external financing.
  • RN's Debt to Equity ratio of 1.42 is on the low side compared to the rest of the industry. RN is outperformed by 70.31% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.42
Debt/FCF N/A
Altman-Z -0.86
ROIC/WACCN/A
WACC7.76%
RN.MI Yearly LT Debt VS Equity VS FCFRN.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M 400M 500M

2.3 Liquidity

  • A Current Ratio of 1.47 indicates that RN should not have too much problems paying its short term obligations.
  • RN has a Current ratio (1.47) which is comparable to the rest of the industry.
  • A Quick Ratio of 0.59 indicates that RN may have some problems paying its short term obligations.
  • Looking at the Quick ratio, with a value of 0.59, RN is in line with its industry, outperforming 40.63% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.47
Quick Ratio 0.59
RN.MI Yearly Current Assets VS Current LiabilitesRN.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. RN.MI Growth Analysis

3.1 Past

  • RN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 25.00%, which is quite impressive.
  • RN shows a strong growth in Revenue. In the last year, the Revenue has grown by 191.49%.
  • RN shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -59.85% yearly.
EPS 1Y (TTM)25%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%96.83%
Revenue 1Y (TTM)191.49%
Revenue growth 3Y-39.29%
Revenue growth 5Y-59.85%
Sales Q2Q%93214.29%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
RN.MI Yearly Revenue VS EstimatesRN.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

More info and screens

Find the best growth stocksShow best growing peers

0

4. RN.MI Valuation Analysis

4.1 Price/Earnings Ratio

  • RN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
RN.MI Price Earnings VS Forward Price EarningsRN.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
RN.MI Per share dataRN.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.01 -0 0.01

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. RN.MI Dividend Analysis

5.1 Amount

  • RN does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

RN.MI Fundamentals: All Metrics, Ratios and Statistics

RISANAMENTO SPA

BIT:RN (4/10/2026, 12:10:02 PM)

0.017

0 (-5.56%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryReal Estate Management & Development
Earnings (Last)10-30
Earnings (Next)05-05
Inst Owners48.9%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap30.61M
Revenue(TTM)26.20M
Net Income(TTM)-26.27M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.17
P/FCF N/A
P/OCF 42.4
P/B 22.78
P/tB 23.42
EV/EBITDA N/A
EPS(TTM)-0.01
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0
FCFYN/A
OCF(TTM)0
OCFY2.36%
SpS0.01
BVpS0
TBVpS0
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -17%
ROE -1954.84%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-10.95%
ROA(5y)-7.97%
ROE(3y)-342.17%
ROE(5y)-214.79%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.17
Health
Industry RankSector Rank
Debt/Equity 1.42
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 294.74%
Cap/Sales 5.34%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.47
Quick Ratio 0.59
Altman-Z -0.86
F-Score5
WACC7.76%
ROIC/WACCN/A
Cap/Depr(3y)179.32%
Cap/Depr(5y)109.66%
Cap/Sales(3y)364.44%
Cap/Sales(5y)228.61%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)25%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%96.83%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)191.49%
Revenue growth 3Y-39.29%
Revenue growth 5Y-59.85%
Sales Q2Q%93214.29%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y28.09%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-100.73%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-99.22%
OCF growth 3YN/A
OCF growth 5YN/A

RISANAMENTO SPA / RN.MI Fundamental Analysis FAQ

What is the fundamental rating for RN stock?

ChartMill assigns a fundamental rating of 1 / 10 to RN.MI.


Can you provide the valuation status for RISANAMENTO SPA?

ChartMill assigns a valuation rating of 0 / 10 to RISANAMENTO SPA (RN.MI). This can be considered as Overvalued.


How profitable is RISANAMENTO SPA (RN.MI) stock?

RISANAMENTO SPA (RN.MI) has a profitability rating of 0 / 10.


What is the financial health of RISANAMENTO SPA (RN.MI) stock?

The financial health rating of RISANAMENTO SPA (RN.MI) is 1 / 10.